About this webinar

Immunogenicity assessment is a critical safety attribute for biotherapeutics undergoing clinical development. Developing clinically relevant immunogenicity assays is essential element for providing route for successful submission. This webinar will discuss some of the challenges faced during the development of immunogenicity methods, as well as present some solutions for resolution of those issues. Our panellists will discuss three different case studies that have been utilised to demonstrate the importance of tailoring the development process to the drug and clinical study requirements.